tiprankstipranks
Trending News
More News >
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market

Enlivex (ENLV) Income Statement

Compare
491 Followers

Enlivex Income Statement

Last quarter (Q3 2025), Enlivex's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Enlivex's net income was $-2.21M. See Enlivex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.28M
Gross Profit
$ -545.00K$ -835.00K$ -777.00K$ -546.00K$ -286.00K
Operating Expenses
$ 14.99M$ 29.39M$ 25.80M$ 19.29M$ 9.79M
Depreciation and Amortization
$ 545.00K$ 835.00K$ 777.00K$ 546.00K$ 286.00K
EBITDA
$ -14.47M$ -28.22M$ -25.02M$ -18.74M$ -9.50M
Operating Income
$ -15.54M$ -29.39M$ -25.80M$ -19.29M$ -9.79M
Other Income/Expenses
$ 522.00K$ 327.00K$ -5.26M$ 4.82M$ -2.04M
Pretax Income
$ -15.01M$ -29.07M$ -31.06M$ -14.47M$ -11.82M
Net Income
$ -15.01M$ -29.07M$ -31.06M$ -14.47M$ -11.82M
Per Share Metrics
Basic EPS
$ -0.73$ -1.56$ -2.31$ -0.54$ -1.05
Diluted EPS
$ -0.73$ -1.56$ -2.31$ -0.54$ -1.05
Weighted Average Shares Outstanding
20.51M 18.57M 18.39M 17.86M 13.17M
Weighted Average Shares Outstanding (Diluted)
20.51M 18.57M 18.39M 17.86M 13.17M
Currency in USD

Enlivex Earnings and Revenue History